Tokyo, Jan. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060364) titled 'Study on the anti-allergic effects of a test substance' on Jan. 15.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Yaizu Suisankagaku Industry Co., Ltd.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To examine the anti-allergic effects of test compounds ingestion.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Ingestion 0mg of test compounds for 12 weeks.
Interv...